A retrospective molecular and phenotypic characterization of a vaccine derived Poliovirus (VDPV) type 1 isolate (7/b/97) isolated from sewages in Athens, Greece in 1997 is reported. VP1 sequencing of the isolate revealed 1.87% divergence from the VP1 region of the reference Sabin 1 strain, while further genomic characterization of isolate 7/b/97, revealed a recombination event in the non-structural part of the genome, between a vaccine and a non vaccine strain probably belonging to Enterovirus species C. Amino-acid substitutions commonly found in previous studies were identified in the capsid coding region of the isolate, while most of the attenuation and temperature sensitivity determinants were reverted. The ultimate source of isolate 7/b/97 is unknown. The recovery of such highly divergent derivatives of vaccine strains emphasizes the need for urgent implementation of environmental surveillance as a supportive procedure in the Polio surveillance system even in countries with high rates of OPV coverage, preventing by this way cases or even outbreaks of poliomyelitis that otherwise would be inevitable.
Introduction
Poliovirus is a positive single strand RNA virus whose genome is approximately 7500 bases in length. It contains four regions: a 5' untranslated region (5' UTR), a coding region, a 3' untranslated region (3' UTR), and a poly (A) tail. After translation of the coding region a polyprotein is produced which is then enzymatically cleaved in order to yield all viral proteins (VP4, VP2, VP3, VP1, 2A, 2B, 2C, 3A, 3B, 3C, 3D).
Poliovirus is the pathogen responsible for paralytic Poliomyelitis and is classified into three serotypes (PV1, PV2, PV3) according to neutralization pattern by monoclonal antibodies specific for each serotype (55) .
The initiative for the eradication of Poliomyelitis worldwide was launched by World
Health Organization in 1988. By the end of 2005, the reported polio-associated cases were declined from 350000 in 1988, to less than 2000. The two basic cornerstones of the initiative for poliomyelitis eradication are massive OPV immunization and sensitive poliovirus surveillance (31) . Surveillance for poliovirus is consisted of investigation of acute flaccid paralysis (AFP) cases and virologic studies of isolates originating either from clinical specimens or the environment (environmental surveillance) (33) .
Environmental surveillance is a powerful and highly sensitive tool for the detection of poliovirus circulation in high-risk areas, in which complete and effective AFP surveillance can not be accomplished. Environmental poliovirus surveillance (EPS) is implemented mainly through investigation of wastewater samples. A previous study proved that EPS is capable of detecting a poliovirus strain even if it is excreted by only 1 out of 10000 people (30) . Furthermore, there are examples of detection of poliovirus strains in the environment even in the absence of reported AFP cases in the population (5, 41, 53) .
A C C E P T E D
The genomes of most RNA viruses are characterized by high evolutional rates, which are many orders of magnitude compared to those of DNA viruses (18) . Poliovirus is considered to be one of the most rapidly evolving among all RNA viruses (22, 39, 42) . The mechanisms underlying rapid poliovirus evolution are mutations and recombination events.
OPV consists of live attenuated poliovirus strains (Sabin strains) of the three poliovirus serotypes. OPV proved to be a very effective vaccine for interrupting wild poliovirus transmission. However, due to its genetic instability there are 2 major disadvantages following its use. The most commonly recognized adverse effect is vaccine associated paralytic poliomyelitis (VAPP), with clinical symptoms identical to those of paralytic poliomyelitis caused by wild poliovirus (33) . During multiplication of Sabin strains in the human intestine, mutations at specific sites of the genome associated with the attenuated phenotype of sabin strains and recombination events between Sabin strains, may result in the loss of the attenuating phenotype of OPV strains and to the acquisition of traits characteristic of wild poliovirus, such as increased neurovirulence and loss of temperature sensitivity (1, 10, 21) .The rate of VAPP worldwide is 1 case per 750000 primary vaccinees (13).
In addition, OPV is the potential source of vaccine derived polioviruses (VDPV). An OPV-related isolate is considered to be VDPV, if the VP1 nucleotide sequence has diverged more than 1% from the VP1 nucleotide sequence of the reference OPV strain (57, 59) . The threshold of ≥1% implies that the replication and/or circulation of the strain
has occurred for at least one year after administration of the OPV dose, substantially longer than 4-6 weeks, which is the normal period of virus replication in the vaccinee. (36) . Ambiguous VDPVs (aVDPVs) is a more recent category, which contains isolates excreted either from vaccinees with no known immunodeficiencies or environmental isolates whose ultimate source has not been identified. aVDPV strains with highly divergent genomes have been isolated from sewage in Israel (53) and Estonia (5) in the absence of reported AFP cases, revealing the importance of environmental surveillance even in adequately immunized populations.
In this paper we report in retrospect the isolation of a vaccine derived poliovirus type 1 isolated from sewage in Athens, Greece in 1997. Almost complete genomic sequencing
revealed the recombinant vaccine / non vaccine nature of this isolate. The ultimate source of the isolate was not known. The results of this study emphasize the need of enhanced environmental surveillance in order to identify highly divergent isolates, which could be a potential source of epidemics, even in regions where the rates of OPV coverage are high.
Materials and Methods

Environmental sampling
Environmental samples were collected from sewage treatment plantation of Athens during The last dilution in which CPE was observed was inoculated in a 25 cm 2 flask of Hep2 cells where the presence of enterovirus was retested as described above.
Preliminary characterization of the isolates
For the preliminary characterization of the isolates, RNA extraction (12) reverse transcription and PCR with primer pair 292-222 (48) were performed. PCR amplicons were sequenced at Macrogen Inc. (Seoul, Korea). After sequencing the identified poliovirus isolates were subjected to further characterization.
Complete VP1 sequencing of poliovirus isolates
The primer pairs used for complete VP1 sequencing were UG1-222 (2, 47) , for the first half of VP1 gene, and serotype specific S 1 37-S 1 688, S 2 30-S 2 688 and S 3 26-S 3 651 for Sabin 1, Sabin 2 and Sabin 3 isolates respectively, for the second half of VP1 (17) . Clustalw (www.ebi.ac.uk/clustalw) was used for the alignment of VP1 sequences of the isolated poliovirus sabin strains to the reference poliovirus sabin strains. The accession numbers of
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reference Sabin strains that were used in this study were AY184219, AY184220 and AY184221 for Sabin 1, Sabin 2 and Sabin 3 respectively. Isolate 7/b/97 demonstrated high sequence divergence from the respective reference Sabin 1 strain and was further studied.
Genomic sequencing of isolate 7/b/97
Reverse transcription and PCR reactions for isolate 7/b/97 were performed in an Table 1) . Analysis of PCR products was performed through agarose gel electrophoresis (2% agarose, 1 µg/ml ethidium bromide in Tris -Boric acid-EDTA buffer) and ladder Hae III ΦX174 (Invitrogen, Life Technologies paisley, UK) was used. Where necessary PCR products were cleaned up by PCR Gel extraction kit (Qiagen GmbH, Hilden). All PCR products were sequenced at Macrogen Inc. (Seoul, Korea).
Computational analysis
Clustalw was used for complete alignment between the genomes of isolate 7/b/97 and 
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RCT marker
In 
Nucleotide sequence accession number
Almost the complete genomic sequence of isolate 7/b/97 (from nt 48 until nt 7406) was submitted to the GenBank library under accession number EF456706.
Results
Preliminary characterization of the isolates -Complete VP1 sequencing
Partial sequencing of VP1 region of the isolates identified five poliovirus isolates. Two of the isolates were of Sabin 2 vaccine origin, two were of Sabin 3 vaccine origin and one was of Sabin 1 vaccine origin.
We further studied the poliovirus isolates by performing complete sequencing of VP1 capsid protein. Complete sequencing of the VP1 genomic region revealed that the isolates of Sabin 2 and Sabin 3 vaccine origin were very closely related to their respective OPV
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reference strains (percentage of homology >99.5%). On the contrary, the isolate 7/b/97 which was found to be of Sabin 1 vaccine origin, revealed 1.87% percentage of divergence in the VP1 region from the VP1 region of the respective OPV reference strain. Thus, it was characterized as a VDPV type 1 and it was further studied by sequencing of a large part of the genome.
Genomic sequencing of isolate 7/b/97
Almost the complete genome (from base 48 until base 7406) of isolate 7/b/97 was sequenced and was aligned with the genome of the reference Sabin 1 strain. Several mutations were identified in 5UTR' and in the capsid coding region and also a recombination event was identified in 2A region of the genome.
In 5 UTR' two mutations were identified, a transition C → T at nucleotide 471 and a transversion C → G at nucleotide 583 (table 2) . Furthermore, the A → G transition at nt 480, which is a well known determinant of loss of the attenuated phenotype of Sabin 1 strains, was not identified (7).
The mutational pattern of the capsid was characterized by preponderance of synonymous versus non-synonymous mutations. Out of the 34 mutations identified in the capsid region, 27 were synonymous (~80%) and only seven were non synonymous (table 2) . Nonsynonymous mutations identified in the capsid are presented in Fig 1 .
In VP4 and VP2 10 synonymous mutations were identified. In VP3 capsid protein, out of seven mutations that were identified, only two resulted in amino-acid substitutions.
Specifically, A→ C transition at nt 1944 resulted in a lysine to threonine substitution of These results suggest that the donor of non-capsid sequences of isolate 7/b/97 is an unidentified strain probably belonging to Enterovirus species C.
A C C E P T E D
RCT marker test
The RCT marker assay showed that isolate 7/b/97 had lost the temperature sensitive 
Discussion
In our current study the retrospective isolation and characterization of a type 1 VDPV isolate, 7/b/97, isolated from sewages in Athens, Greece in 1997, is reported. Genomic sequencing revealed that this isolate has been originated from a recombination event between Sabin 1 and an unidentified enterovirus belonging to species C. Moreover, aminoacid substitutions, frequently found in previous studies, were scattered throughout the capsid. The important finding of the present report is that highly divergent vaccine derivatives can be found even in communities with high immunization levels and that environmental surveillance for poliovirus should be permanent even in countries considered as polio free.
Two mutations were identified in 5 UTR'. Nucleotide 471 where a C → T transition was identified, is located in a single strand part of domain V, while nt 583 where a C → G transversion was observed, is located in a double strand region of domain VI (50) . 
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Residue 106 of VP1 is also located in VP1 BC loop and is participating in virus-receptor interactions. Amino-acid 237 leans towards the inner surface of the capsid, and is located next to GH loop of VP1, a region which participates in the formation of the canyon floor (4, 16, 26, 37) .
It has been proved that certain amino-acids located in the antigenic sites of Sabin 1 strains (aa 60 of VP3, aa 106, 99 and 90 of VP1) are changing very rapidly once the virus replicate in the human intestine, into the respective wild type amino-acids or into aminoacids homotypic to the respective residues of wild type virus. The very early fixation of these substitutions probably indicates that they are not the result of immune evasion and they might reflect an effort for adaptation of the virus in the human intestine (61) .
Considering the fact that many of these substitutions were identified in the capsid coding region of isolate 7/b/97 and also in many previous studies (3, 15, 17, 23, 34, 43) (38, 39) . Furthermore, we can suggest that recombination may increase the fitness of isolate 7/b/97 by substituting the temperature sensitivity determinants mapped to the 3Dpol and 3' UTR of the isolate. This is actually true for 3Dpol, since amino-acid 73 was substituted from histidine to tyrosine of the wild type virus (unfortunately we can not know for 3 UTR since we obtained the
genomic sequence of the isolate from nt 48 to nt 7406). This suggestion is also supported by recent phylogenetic studies, which propose that polioviruses and species C enteroviruses are distinct capsid sequences in quest of non-capsid sequences of the highest fitness (8).
According to W.H.O criteria, isolate 7/b/97 is characterized as ambiguous VDPV (aVDPV). Nevertheless, genomic evidence presented here could classify isolate 7/b/97 in the category of cVDPV. Firstly, the variability among antigenic sites is limited despite the high degree of nucleotide divergence of the isolate, and secondly and most importantly, the recombination in the non-structural part of the genome with an unidentified species C enterovirus strain demonstrates evidence of circulation of the isolate in the population (33, 52, 60) . However, there were no polio epidemics or suspected poliomyelitis cases neither gaps in OPV coverage nor any other conditions, that may benefit cVDPV emergence and spread in Greece during the time period the virus was isolated. We can hypothesize, therefore, that strain 7/b/97 is more likely to be an iVDPV strain that had been excreted from an unidentified source.
Although AFP surveillance is one of the two major cornerstones in poliovirus eradication task force, environmental surveillance has been proven to be a highly sensitive tool in some situations. Environmental surveillance has the potential of identifying poliovirus in the environment, even in the absence of paralytic poliomyelitis cases. For example, highly divergent VDPVs were isolated in Finland, Israel, and in Estonia in the absence of suspected poliomyelitis cases (5, 41, 53) . Furthermore, indigenous type 1 wild poliovirus was identified in environmental samples in Egypt, even after OPV immunization campaigns (19) . The high sensitivity advantage of environmental surveillance should be
implemented during and after poliovirus eradication, preventing cases or even outbreaks of paralytic poliomyelitis that otherwise would be inevitable (54).
In conclusion, we reported the genomic and phenotypic characterization of an environmental aVDPV isolate ( Intensive research for optimal vaccination strategies for the final stages of polio eradication and the post-eradication era should be urgently promoted. For this visualization the capsid protomer structure of Poliovirus type 1, Mahoney strain, was used 1ASJ.pdb (56) . Figure 2a . Simplot analysis of the complete genome of isolate 7/b/97. Isolate 7/b/97 is compared with isolates Sabin 1 (AY184219) and CAV15 strain G-9 (AF465512). Figure 2b . Simplot analysis of the complete genome of isolate 7/b/97. Isolate 7/b/97 is compared with isolates Sabin 1 (AY184219), CAV15 strain G-9 (AF465512), CAV17 strain G12 (AF499639), CAV18 strain G-13 (AF465513) and strain EGY93_034 (AF448783).
